C4 Therapeutics, Inc.: cashflow_investing
| Value | {"amount": 68046000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-06-30 |
| Status | current |
| Entity | C4 Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:06:05.352034+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2162b51d-f65a-42c1-b7c2-667b02834f8d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-25-038587Retrieved: 2026-08-19T17:06:05.352034+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001662579/cashflow-investing/2025-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2162b51d-f65a-42c1-b7c2-667b02834f8d
History
- no predecessors — first report